![Valerie Jolliffe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Valerie Jolliffe
Director Ejecutivo en Javelin Ventures Ltd. .
Perfil
Valerie Celia Jolliffe is currently the Chief Executive Officer at Javelin Ventures Ltd.
and a Principal at Chrysalis VCT Management Ltd.
She is also a Trustee at Practical Action, Beat, Alcohol Research UK, and Imperial Health Charity.
In the past, she worked as a Director at Odontis Ltd., a Non-Executive Director at OSspray Ltd., and a Secretary at Vaxome Ltd.
Cargos activos de Valerie Jolliffe
Empresas | Cargo | Inicio |
---|---|---|
Javelin Ventures Ltd.
![]() Javelin Ventures Ltd. Investment ManagersFinance Javelin Ventures Ltd (Javelin Ventures) is a venture capital firm founded in 2001 by Valerie Jolliffe and Janis Anderson. The firm is headquartered in London, United Kingdom. | Director Ejecutivo | 01/01/2001 |
Beat
![]() Beat Investment Trusts/Mutual FundsMiscellaneous Beat provides healthcare services. The company was founded in 1989 and is headquartered in Norwich, the United Kingdom. | Director/Miembro de la Junta | 01/01/2012 |
Chrysalis VCT Management Ltd.
![]() Chrysalis VCT Management Ltd. Investment ManagersFinance Chrysalis VCT Management Ltd. (Chrysalis) is an independent UK venture capital firm which was established in 1998 to manage the Chrysalis VCT PLC a Venture Capital Trust. The firm is headquartered in London. | Inversor de Capital Privado | - |
Practical Action
![]() Practical Action Investment Trusts/Mutual FundsMiscellaneous Practical Action is a development charity that utilizes technology to combat poverty in developing countries. The non-profit company is based in Rugby, UK and has subsidiaries in the United Kingdom. The British company was founded in 1966 by Fritz Schumacher, and Paul Smith Lomas has been the CEO of the company since 2010. | Director/Miembro de la Junta | - |
Alcohol Research UK
![]() Alcohol Research UK Miscellaneous Commercial ServicesCommercial Services Alcohol Research UK is an alcohol charity that aims to reduce the harm caused by alcohol. The non-profit company is based in London, UK. The British company fund, commission, and conducts high-quality research to enrich the knowledge base and improve the lives of those affected by alcohol harm. The company was founded in 2017. The CEO is Richard Piper. | Director/Miembro de la Junta | - |
Imperial Health Charity
![]() Imperial Health Charity Miscellaneous Commercial ServicesCommercial Services Imperial Health Charity is an organization that provides funding to community organizations working to improve the health and wellbeing of people most affected by Covid-19. The non-profit company is based in London, UK. The British company has committed £360,000 to this cause. The charity also partners with museums to help patients experience culture in the capital. Ian Lush has been the CEO of the company since 2014. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Valerie Jolliffe.
Empresas | Cargo | Fin |
---|---|---|
Odontis Ltd.
![]() Odontis Ltd. Miscellaneous Commercial ServicesCommercial Services Odontis is developing a biological replacement tooth product - the BioToothTM. The research is lead by Professor Paul Sharpe at King's College London Dental Institute. His team has demonstrated that tooth development can be initiated in stem cells, and that fully formed teeth can be created in developmental models. This is pioneering in that it represents one of the very few examples of a fully integrated tissue engineered organ. The technology opens the potential for the implantation of cultured cells in patients to grow and replace damaged or missing teeth. Odontis has attracted over £2 million of funding to date to progress the technology to commercial development. | Director/Miembro de la Junta | 18/01/2011 |
Vaxome Ltd.
![]() Vaxome Ltd. Pharmaceuticals: MajorHealth Technology Vaxome Ltd. developed vaccine delivery technology. The firm offered a novel vaccine delivery technology for antigen presentation and delivery system for stimulating T cell-mediated immune responses. The company was founded by Ping Wang in 2004 and was headquartered in London, the United Kingdom. | Secretario Corporativo | - |
OSspray Ltd.
![]() OSspray Ltd. Chemicals: Major DiversifiedProcess Industries OSspray Ltd. provides bioactive powders for teeth cutting, cleaning and whitening. It engages in the innovation of biomaterials for minimally invasive dentistry of therapeutic air polishing solutions that restore and maintain tooth structure and overall oral health. The company was founded in 2004 by Paul Robinson, Larry Hench and Ian Dennis Thompson and is headquartered in London, GB. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 9 |
---|---|
Javelin Ventures Ltd.
![]() Javelin Ventures Ltd. Investment ManagersFinance Javelin Ventures Ltd (Javelin Ventures) is a venture capital firm founded in 2001 by Valerie Jolliffe and Janis Anderson. The firm is headquartered in London, United Kingdom. | Finance |
Chrysalis VCT Management Ltd.
![]() Chrysalis VCT Management Ltd. Investment ManagersFinance Chrysalis VCT Management Ltd. (Chrysalis) is an independent UK venture capital firm which was established in 1998 to manage the Chrysalis VCT PLC a Venture Capital Trust. The firm is headquartered in London. | Finance |
Odontis Ltd.
![]() Odontis Ltd. Miscellaneous Commercial ServicesCommercial Services Odontis is developing a biological replacement tooth product - the BioToothTM. The research is lead by Professor Paul Sharpe at King's College London Dental Institute. His team has demonstrated that tooth development can be initiated in stem cells, and that fully formed teeth can be created in developmental models. This is pioneering in that it represents one of the very few examples of a fully integrated tissue engineered organ. The technology opens the potential for the implantation of cultured cells in patients to grow and replace damaged or missing teeth. Odontis has attracted over £2 million of funding to date to progress the technology to commercial development. | Commercial Services |
OSspray Ltd.
![]() OSspray Ltd. Chemicals: Major DiversifiedProcess Industries OSspray Ltd. provides bioactive powders for teeth cutting, cleaning and whitening. It engages in the innovation of biomaterials for minimally invasive dentistry of therapeutic air polishing solutions that restore and maintain tooth structure and overall oral health. The company was founded in 2004 by Paul Robinson, Larry Hench and Ian Dennis Thompson and is headquartered in London, GB. | Process Industries |
Practical Action
![]() Practical Action Investment Trusts/Mutual FundsMiscellaneous Practical Action is a development charity that utilizes technology to combat poverty in developing countries. The non-profit company is based in Rugby, UK and has subsidiaries in the United Kingdom. The British company was founded in 1966 by Fritz Schumacher, and Paul Smith Lomas has been the CEO of the company since 2010. | Miscellaneous |
Beat
![]() Beat Investment Trusts/Mutual FundsMiscellaneous Beat provides healthcare services. The company was founded in 1989 and is headquartered in Norwich, the United Kingdom. | Miscellaneous |
Alcohol Research UK
![]() Alcohol Research UK Miscellaneous Commercial ServicesCommercial Services Alcohol Research UK is an alcohol charity that aims to reduce the harm caused by alcohol. The non-profit company is based in London, UK. The British company fund, commission, and conducts high-quality research to enrich the knowledge base and improve the lives of those affected by alcohol harm. The company was founded in 2017. The CEO is Richard Piper. | Commercial Services |
Imperial Health Charity
![]() Imperial Health Charity Miscellaneous Commercial ServicesCommercial Services Imperial Health Charity is an organization that provides funding to community organizations working to improve the health and wellbeing of people most affected by Covid-19. The non-profit company is based in London, UK. The British company has committed £360,000 to this cause. The charity also partners with museums to help patients experience culture in the capital. Ian Lush has been the CEO of the company since 2014. | Commercial Services |
Vaxome Ltd.
![]() Vaxome Ltd. Pharmaceuticals: MajorHealth Technology Vaxome Ltd. developed vaccine delivery technology. The firm offered a novel vaccine delivery technology for antigen presentation and delivery system for stimulating T cell-mediated immune responses. The company was founded by Ping Wang in 2004 and was headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Valerie Jolliffe